INSIGHTS ON CLINICAL TRIAL DESIGN
-
![lack_of_rtsm_reusability_surprises_every_sponsor_v1]( "Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial Sponsor")
Lack Of IRT/RTSM System Reusability Surprises Every Clinical Trial SponsorStop re-learning your IRT system with every new trial. Uncover why "standard" features often hide custom complexities that slow down UAT and clinical operations.
-
![Clinical Endpoints]( "A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT Data")
A Framework For Selecting Reliable Clinical Endpoints From Real-World DHT DataDr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
-
![Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip]( "Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip?")
Can Your RTSM Software Vendor Handle Your Clinical Trial's Timeline Slip?This clip examines why shifting study timelines expose weaknesses in rigid RTSM systems and highlights how flexible technology helps trials stay on track when plans inevitably change.
-
![patient enrollment recruitment iStock-922106872]( "What Is Direct-To-Patient Clinical Trial Recruitment?")
What Is Direct-To-Patient Clinical Trial Recruitment?What is the direct-to-patient (DtP) recruitment, and how can sponsors and organizers leverage this approach to boost patient recruitment and achieve clinical trial goals?
-
DCT Solutions That Successfully Deliver Results10/28/2025
Catch MRN COO, Todd McGrath, speaking on the impact DCT/hybrid trial design can have on overall trial success, noting that there is no "one-size-fits-all" — it takes a tailored approach to achieve maximum results.
-
Breaking Barriers In Drug Development: Time, Trust And Putting Patients First1/16/2025
Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.
-
Phase 1 Trial In Painful Diabetic Peripheral Neuropathy2/24/2026
A complex Phase 1 neuropathy study with overnight stays achieved full enrollment and retention through careful planning, strong participant engagement, and disciplined operational execution.
-
What Clinical Trial Decision Makers Are Prioritizing In 20255/7/2025
In 2025, clinical trial operations are undergoing a transformative shift driven by the need for speed, cost-efficiency, and patient-centered approaches.
-
The Benefit Of Applying Corporate Meetings Management Best Practices12/8/2025
Discover how a structured, scalable approach to patient support can streamline trial operations, improve retention, and elevate the clinical experience for everyone involved.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Doctor-Comforting-Patient-GettyImages-157718473]( "Metabolic Disorders")
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
![GettyImages-2189405678-GLP-1-obesity]( "Precision Partnership For Obesity Clinical Trials")
Accelerate obesity research with specialized expertise in GLP-1 trials. Our approach ensures rapid enrollment, high participant retention, and clean data through a patient-centered model.
-
![GettyImages-1302454470 drug review]( "Why Central IRBs Matter For Efficient Clinical Trials")
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
![GettyImages-1407258556 patient]( "Even The Most Complex Studies Reach Milestones Faster")
Whether it's complex randomization, adaptive trials, Direct-to-Patient models, or recurring visit cycles, discover how Rave RTSM is able to grant your team instant access to the full spectrum of current and forthcoming study features.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "How Trial Compass Is Solving Psychiatric Trial Enrollment")
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
